A tiny amino acid tweak that can help peptides go oral
A medicinal-chemistry study suggests one residue, Aib, can sometimes ‘pre-organize’ macrocyclic peptides so they cross membranes more easily, improving oral exposure in mice. It is scaffold-dependent, not magic.
“Oral peptides” is a phrase people use like it is a product category. In practice, it is a pile of constraints.
Most peptides are chewed up by digestive enzymes and do not cross the gut wall easily. Even if a peptide survives, its backbone tends to be polar, which makes slipping through a membrane feel like trying to push a wet sponge through wax.
That is why a lot of progress in oral peptide drug discovery is not about discovering a new receptor. It is about learning how to build molecules that can temporarily hide their own polarity.
A new Journal of Medicinal Chemistry paper proposes a design trick that sometimes helps: swapping certain residues for α‑aminoisobutyric acid (Aib), a nonstandard amino acid that tends to “pre-organize” peptide shape (PubMed).
The intuition: fewer shapes, fewer penalties
Macrocyclic peptides can behave differently from linear peptides because the ring can lock in intramolecular hydrogen bonds and reduce flexibility.
But not all macrocycles are locked enough. A flexible macrocycle may adopt one set of shapes in water, then need to rearrange into a different set of shapes to cross a membrane. That rearrangement costs energy, and that cost shows up as poor passive permeability.
Aib is known to bias peptide backbones toward certain conformations. The authors’ argument is that Aib can help some macrocycles arrive “pre-folded” into shapes that cross membranes more readily.
What they did (high level)
They tested multiple small macrocyclic scaffolds, made systematic substitutions, and used several structure-focused methods to support the conformational story.
The important result is not “Aib makes peptides oral.” It is that Aib helped some scaffolds and did not help others.
What they report
From the abstract-level summary, they report:
- Aib can enforce turns and stabilize intramolecular hydrogen bonds
- in some scaffolds, permeability improved substantially (reported up to ~8-fold)
- some modified macrocycles showed improved oral exposure in mice, consistent with better absorption
- scaffolds that were already highly preorganized did not benefit much
That last point is the grown-up takeaway. This is a scaffold-dependent knob, not a universal spell.
A curious-reader question: why would one residue matter?
Because for peptides, shape is often the product.
When a small molecule changes one atom, it can change binding. When a peptide changes one residue, it can change the entire conformational ensemble, which changes how many hydrogen bond donors are exposed, how “greasy” the surface looks, and how often the molecule samples a membrane-crossing posture.
So a single residue can plausibly shift absorption. The hard part is predicting when.
The follow-up that decides it
The next persuasive step is applying the Aib strategy to macrocycles that already have real target biology and then seeing whether better exposure translates into better effects.